Keyphrases
A(H1N1)
60%
Addition Strategy
20%
Age-adjusted
20%
Antibody Response
20%
Antibody Titer
20%
Appropriate Responses
20%
B-type
60%
Blood Samples
40%
Chronic Heart Failure
20%
Control Subjects
80%
Delayed Hypersensitivity
20%
Footpad
20%
H3N2
60%
Healthy Controls
60%
Hemagglutination Inhibition
20%
Hospital Laboratory
20%
Influenza Vaccination
100%
Influenza Vaccine
80%
Influenza-like Illness
20%
Low Response
20%
New Antigens
40%
Optimal Treatment
20%
Patients with Chronic Heart Failure
100%
Patients with Heart Failure
100%
Peripheral Blood Mononuclear Cells
20%
Physiologic Conditions
20%
Research Laboratories
20%
SCID Mice
20%
Severe Combined Immunodeficiency
20%
Single-center Study
20%
T Cell Immune Response
60%
T Cell Response
100%
T Cells
20%
Trivalent Inactivated
20%
University Hospital
20%
University Research
20%
Vaccination
40%
Vaccine Antigen
20%
Immunology and Microbiology
Adoptive Immunity
14%
Antibody Response
14%
Antibody Titer
14%
Delayed Hypersensitivity
14%
Hemagglutination Inhibition
14%
Immune Response
28%
Influenza
100%
Influenza A Virus (H1N1)
42%
Influenza A Virus (H3N2)
42%
Influenza Vaccine
57%
Mouse
14%
Peripheral Blood Mononuclear Cell
14%
SCID Mouse
14%
Sensitization
14%
Severe Combined Immunodeficiency
14%
T Cell
100%
Type Strain
14%
Vaccination Policy
100%
Vaccine Efficacy
28%
Nursing and Health Professions
Antibody Titer
14%
Clinician
14%
Delayed Hypersensitivity
14%
Heart Failure
100%
Influenza
14%
Influenza Vaccination
100%
Influenza Vaccine
57%
Severe Combined Immunodeficiency
14%
Type Strain
14%
University Hospital
14%
Vaccination Policy
28%
Vaccine Efficacy
28%